Planning for Performance Evaluation Under the IVDR
Even for those that have prepared a performance evaluation summary document for an IVD CE marked under the IVDD…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 55–63 of 72
Even for those that have prepared a performance evaluation summary document for an IVD CE marked under the IVDD…
Given their scope, the labeling requirements established under the IVDR can be daunting for manufacturers, even for legacy device…
In this article, we share the advantages and disadvantages associated with consolidating the roles of authorized representative and importer.
More than 30 years since the Product Liability Directive (PLD) was established and after the Commission assessed its regulatory…
One of the (many) significant changes brought about by the EU In Vitro Diagnostic Medical Device Regulation…
If your plan was to wait until 2023 to leisurely address compliance with the Medical Device Regulation (MDR 2017/745) and…
Yes, it’s true. No, it’s not new. Yes, you need to take it more seriously than ever before. Here’s why. (Or skip the explanation and go directly to the language requirements..
Many medical device manufacturers located outside the European Union have been wondering what to make of Article 13 of the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).
How do we break this to you gently? OK we can't. The blunt answer is no. Starting May 26, 2021 there are some aspects of the European Medical Device Regulation (MDR 2017/745)
Showing 55–63 of 72